Candel Therapeutics, Inc. (CADL)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

($1.10M) Net Amount

Buy:	0	--
Sell:	($1.10M)	$5.97 - $6.47

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

1

(2)

0

(1)

8

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
Yesterday 3:07 PM View:	Yesterday Option Exercise $20.00K	Tak Paul Peter Chief Executive Officer Director		Candel Therapeutics, Inc. - CADL	45% 236.89K to 343.63K	0	($267.03K) (18%)	--	$5.97 - $6.47	Show Txns Hide Txns

19-Jul-24 8:24 AM View:	17-Jul-24 Market Sale ($90.95K)	Barone Francesca Chief Scientific Officer		Candel Therapeutics, Inc. - CADL	71% 93.61K to 159.96K	0	($166.48K) (29%)	--	$5.97 - $6.47	Show Txns Hide Txns

19-Jul-24 8:26 AM View:	17-Jul-24 Market Sale ($70.39K)	Nichols Garrett Chief Medical Officer		Candel Therapeutics, Inc. - CADL	96% 58.48K to 114.48K	0	($128.74K) (35%)	--	$5.97 - $6.47	Show Txns Hide Txns

30-Nov-23 5:00 PM View:	28-Nov-23 Payment of Exercise ($18.14K)	Amello Jason Chief Financial Officer		Candel Therapeutics, Inc. - CADL	109% 96.44K to 202.01K	0	0	--	--	Show Txns Hide Txns

19-Jul-24 8:31 AM View:	17-Jul-24 Market Sale ($96.12K)	Tyagarajan Seshu Chief Technology Officer		Candel Therapeutics, Inc. - CADL	68% 87.04K to 146.05K	0	($175.75K) (32%)	--	$5.97 - $6.47	Show Txns Hide Txns

19-Jul-24 8:28 AM View:	17-Jul-24 Market Sale ($63.98K)	Schoch Charles See Remarks		Candel Therapeutics, Inc. - CADL	(23%) 81.3K to 62.52K	0	($117.12K) (23%)	--	$5.97 - $6.47	Show Txns Hide Txns

15-Oct-24 5:59 PM View:	15-Oct-24 Market Sale ($62.78K)	Aguilar-Cordova Estuardo 10% Owner		Candel Therapeutics, Inc. - CADL	(1%) 6.09M to 6.05M	0	($243.83K) (1%)	--	$6.02 - $6.05	Show Txns Hide Txns